Rhumbline Advisers Maravai Lifesciences Holdings, Inc. Transaction History

Rhumbline Advisers

$121 Billion
Q3 2025

A detailed history of Rhumbline Advisers transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 174,581 shares of MRVI stock, worth $635,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,581

Previous 195,272 10.6%

Holding current value

$635,474

Previous $470,000 6.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$2.03 - $2.89 $42,002 - $59,796	-20,691 Reduced 10.6%	174,581 $501,000
Q2 2025 Aug 12, 2025	BUY	$1.72 - $2.47 $56,656 - $81,361	32,940 Added 20.29%	195,272 $470,000
Q1 2025 Apr 08, 2025	SELL	$2.21 - $6.13 $50,584 - $140,309	-22,889 Reduced 12.36%	162,332 $383,000
Q4 2024 May 29, 2025	BUY	$4.42 - $8.5 $101,169 - $194,556	22,889 Added 14.1%	185,221 $1.01 Million
Q4 2024 Jan 30, 2025	BUY	$4.42 - $8.5 $73,867 - $142,052	16,712 Added 9.92%	185,221 $1.01 Million

Q3 2024 Nov 12, 2024	SELL	$6.84 - $9.73 $20,383 - $28,995	-2,980 Reduced 1.74%	168,509 $1.4 Million
Q2 2024 Aug 01, 2024	BUY	$6.87 - $11.34 $274,490 - $453,089	39,955 Added 30.38%	171,489 $1.23 Million
Q1 2024 May 09, 2024	SELL	$5.11 - $8.76 $75,229 - $128,964	-14,722 Reduced 10.07%	131,534 $1.14 Million
Q4 2023 Feb 08, 2024	BUY	$4.7 - $9.87 $43,846 - $92,077	9,329 Added 6.81%	146,256 $957,000
Q3 2023 Nov 09, 2023	SELL	$9.14 - $12.85 $203,913 - $286,683	-22,310 Reduced 14.01%	136,927 $1.37 Million
Q2 2023 Aug 08, 2023	BUY	$12.09 - $15.0 $345,084 - $428,145	28,543 Added 21.84%	159,237 $1.98 Million
Q1 2023 May 11, 2023	BUY	$12.99 - $16.48 $161,894 - $205,390	12,463 Added 10.54%	130,694 $1.83 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $84,362 - $167,240	6,749 Added 6.05%	118,231 $1.69 Million
Q3 2022 Nov 10, 2022	BUY	$20.6 - $30.37 $114,968 - $169,494	5,581 Added 5.27%	111,482 $2.85 Million
Q2 2022 Aug 11, 2022	BUY	$26.05 - $37.48 $316,898 - $455,944	12,165 Added 12.98%	105,901 $3.01 Million
Q1 2022 May 12, 2022	SELL	$24.46 - $40.92 $65,846 - $110,156	-2,692 Reduced 2.79%	93,736 $3.31 Million
Q4 2021 Feb 10, 2022	BUY	$35.0 - $45.94 $405,195 - $531,847	11,577 Added 13.64%	96,428 $4.04 Million
Q3 2021 Nov 12, 2021	BUY	$36.8 - $60.62 $636,566 - $1.05 Million	17,298 Added 25.61%	84,851 $4.16 Million
Q2 2021 Aug 05, 2021	BUY	$32.46 - $45.0 $119,777 - $166,050	3,690 Added 5.78%	67,553 $2.82 Million
Q1 2021 May 06, 2021	BUY	$25.8 - $38.49 $1.65 Million - $2.46 Million	63,863 New	63,863 $2.28 Million

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Maravai Lifesciences Holdings, Inc. Transaction History